North America Medical Clinical Nutrition Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 29.88 Billion |
| Market Size (2029) | USD 40.35 Billion |
| CAGR (2024 - 2029) | 6.19 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
North America Medical Clinical Nutrition Market Analysis
The North America Clinical Nutrition Market size is estimated at USD 29.88 billion in 2024, and is expected to reach USD 40.35 billion by 2029, growing at a CAGR of 6.19% during the forecast period (2024-2029).
COVID-19 has significantly impacted the growth of the clinical nutrition market in North America. The increasing risks associated with COVID-19 led to more consumption of clinical nutrition. The research studies conducted to demonstrate the effectiveness of clinical nutrition are also expected to drive the growth of the market studied. For instance, the article 'The Central Role of Clinical Nutrition in COVID-19 Patients During and After Hospitalization in Intensive Care Unit' published in July 2020, suggested that proper evidence-based nutritional therapy was reported for patients with critical COVID-19 conditions and recommended to be included in life-saving therapies. Thus, COVID-19 has impacted market growth during the pandemic.
Certain factors that are propelling the market growth are the increasing prevalence of metabolic disorders, rising spending on healthcare by government and private foundations, and the rising aging population in North American countries.
The growing burden of metabolic disorders is the key factor driving the market growth. For instance, according to statistics published by the International Diabetes Federation, in the 10th edition of 2021, 2,974.0 thousand people were living with diabetes in 2021 in Canada. In addition, as per the same source, this number is projected to reach 3,288.2 thousand by 2030 and 3,468.5 thousand by 2045. Therefore, high blood sugar caused by diabetes can damage the nerves that control the heart and blood vessels, leading to a variety of cardiovascular diseases like coronary artery disease and stroke. This is expected to increase the demand for clinical nutrition to maintain their glucose level, thereby bolstering the market growth.
Additionally, obesity in the Mexican population is found to be the most prevalent heart disease risk factor which is also contributing to the growth of the studied market over the forecast period. For instance, according to 2022 statistics published by World Obesity Federation, it has been observed that 31.5% of men and 40.2% of women are living with obesity in Mexico in 2020. Thus, the growing cases of metabolic disorders among the population in the region are contributing to the market growth over the forecast period.
Furthermore, the growing geriatric population is more prone to develop metabolic disorders due to multiple age-related physiologic mechanisms which are expected to increase the demand for clinical nutrition, thereby propelling the market growth. For instance, according to the 2022 statistics published by the United Nations Population Fund, in Canada, a large proportion of the living population is aged 15-64 and accounts for 65% in 2022. In addition, as per the same source, 19% of the population is aged 65 years and above in 2022. This is expected to boost market growth over the forecast period. The geriatric population shows more vulnerability to diseases that require clinical nutrition, thereby propelling market growth over the forecast period.
However, the imprecise perception of clinical nutrition and the reduction in birth rates are some of the factors that are restraining the market growth over the forecast period.
North America Medical Clinical Nutrition Market Trends
This section covers the major market trends shaping the North America Medical Clinical Nutrition market according to our research experts:
Pediatric Segment Expects to Register a High CAGR in the North America Clinical Nutrition Market Over the Forecast Period
The pediatric segment is expected to witness significant growth in the North America clinical nutrition market over the forecast period owing to the factors such as rising metabolic disorders such as diabetes, cancer, and others in the pediatric population and growing demand for clinical nutrition.
For newborns and young children to grow and develop properly, they must receive adequate nutrition. A well-balanced diet boosts a child's immune system, supports healthy weight maintenance, and promotes bone and brain growth. Hence, pediatric clinical nutrition is an integral part of the market studied.
According to the data published by the American Cancer Society in July 2022, around 10,500 children in the United States under 15 were diagnosed with cancer in 2021. Childhood cancer rates rose slightly over the past few decades. Cancer patients are dependent on nutritional support even after treatment. Hence, with increasing cancer cases in pediatrics, nutritional support for the same will also show growth in the upcoming future.
Furthermore, the rising company's focus on developing nutritional products and growing product launches in the region is also contributing to the market growth. For instance, in November 2021, Abbott launched Similac 360 Total Care, the first and only infant formula in the United States with a blend of five different Human Milk Oligosaccharides (HMOs), previously only found together in breast milk. The product provides nutrition to support a baby's complete health and development, including the immune system, digestive system, and brain. Also, in June 2022, Else Nutrition was launched in Canada for the manufacture and distribution of its key products, super cereals, toddler nutrition and kid protein shakes.
Thus, owing to the aforementioned factors, the market is expected to grow significantly during the forecast period.
United States iss Expected to Have the Significant Market Share Over the Forecast Period
The United States is expected to witness significant growth in the North America clinical nutrition market over the forecast period. The factors attributing to the market growth are the increasing prevalence of metabolic disorders, rising spending on healthcare by the government, and the growing aging population.
In addition, the rising geriatric population who are more vulnerable to developing chronic diseases due to their weak immunity in the country is also expected to increase the market growth. For instance, according to the 2020 Profile of Older Americans published by the Administration for Community Living in May 2021, around 54.1 million people in the United States were above the age of 65 years. The numbers were projected to rise to 80.8 million in 2040 and 94.7 million by 2060.
Furthermore, the increasing awareness among the people about their health and the increasing expendable income leads to high expenditure on healthcare. For instance, according to the Organization for Economic Co-operation and Development (OECD), in June 2022, the United States and Mexico's healthcare spending in 2021 was 17.8% and 6.2% of the total GDP of the countries, respectively. Additionally, the data updated by the Centers for Medicare and Medicaid Services (CMS) in December 2021 reported that healthcare spending in the United States grew 9.7% in 2020 and reached USD 4.1 trillion or USD 12,530 per person. And as a share of the nation's Gross Domestic Product, health spending accounted for 19.7% share of the country's gross domestic product (GDP). Such equitable, responsive, and efficient health systems have greatly facilitated medical and nutritional needs awareness among the population. This is likely to have a positive impact on the growth of the market studied.
Moreover, the rising company activities in developing new products that mainly focused on parenteral nutrition are also contributing to the market growth in the country. For instance, in September 2021, American Regent launched Multrys which is indicated in neonatal and pediatric patients weighing less than 10 kg as a source of zinc, copper, manganese, and selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. Due to such launches, the segment is expected to witness significant growth in the future.
Thus, owing to the aforementioned factors, the market is expected to grow significantly during the forecast period.
North America Medical Clinical Nutrition Industry Overview
The North America clinical nutrition market is consolidated with the presence of several international major players, as well as domestic companies in the United States, Canada, and Mexico, which creates a good competitive scenario for companies in the North American clinical nutrition market. Some of the major companies having a good presence across the North American region include Abbott, Nestle, Baxter, B Braun, Danone Nutricia, and Pfizer.
North America Medical Clinical Nutrition Market Leaders
-
Abbott Laboratories (Abbott Nutrition)
-
Nestlé SA
-
Baxter
-
B. Braun Melsungen AG
-
Danone Nutricia
*Disclaimer: Major Players sorted in no particular order
North America Medical Clinical Nutrition Market News
- In April 2022, Abbott released limited quantities of metabolic nutrition formulas for infants in the market after the approval of the United States Food and Drug Administration.
- In January 2022, Guardion Health Sciences, Inc launched a new branded Shopify store to promote and raise the selling of its Viactiv line of products.
North America Medical Clinical Nutrition Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Metabolic Disorders
- 4.2.2 High Healthcare Spending by Government and Private Foundations
- 4.2.3 Growing Aging Population in North American Countries
-
4.3 Market Restraints
- 4.3.1 Imprecise Perception about Clinical Nutrition
- 4.3.2 Reduction in Birth Rates
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Route of Administration
- 5.1.1 Oral and Enteral
- 5.1.2 Parenteral
-
5.2 By Application
- 5.2.1 Nutritional Support for Malnutrition
- 5.2.2 Nutritional Support for Metabolic Disorders
- 5.2.3 Nutritional Support for Gastrointestinal Diseases
- 5.2.4 Nutritional Support for Neurological Diseases
- 5.2.5 Nutritional Support in Cancer
- 5.2.6 Nutritional Support in Other Indications
-
5.3 By End User
- 5.3.1 Pediatric
- 5.3.2 Adult
-
5.4 Geography
- 5.4.1 United States
- 5.4.2 Canada
- 5.4.3 Mexico
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Abbott Nutrition
- 6.1.2 B. Braun Melsungen AG
- 6.1.3 BASF SE
- 6.1.4 Baxter Healthcare
- 6.1.5 Nestle Health Science
- 6.1.6 Danone S.A. (Nutricia)
- 6.1.7 Fresenius Kabi
- 6.1.8 Perrigo Company PLC
- 6.1.9 Reckitt Benckiser
- 6.1.10 Baxter
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityNorth America Medical Clinical Nutrition Industry Segmentation
As per the scope of the report, clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. A higher number of premature births also demand advanced clinical nutrition. The North America Clinical Nutrition Market is Segmented by Route of Administration (Oral and Enteral, Parenteral), Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Neurological Diseases, Cancer, Other Indications), End-User (Pediatric and Adult), and Geography (United States, Canada, and Mexico). The report offers the value (in USD million) for the above segments.
| By Route of Administration | Oral and Enteral |
| Parenteral | |
| By Application | Nutritional Support for Malnutrition |
| Nutritional Support for Metabolic Disorders | |
| Nutritional Support for Gastrointestinal Diseases | |
| Nutritional Support for Neurological Diseases | |
| Nutritional Support in Cancer | |
| Nutritional Support in Other Indications | |
| By End User | Pediatric |
| Adult | |
| Geography | United States |
| Canada | |
| Mexico |
North America Medical Clinical Nutrition Market Research FAQs
How big is the North America Clinical Nutrition Market?
The North America Clinical Nutrition Market size is expected to reach USD 29.88 billion in 2024 and grow at a CAGR of 6.19% to reach USD 40.35 billion by 2029.
What is the current North America Clinical Nutrition Market size?
In 2024, the North America Clinical Nutrition Market size is expected to reach USD 29.88 billion.
Who are the key players in North America Clinical Nutrition Market?
Abbott Laboratories (Abbott Nutrition), Nestlé SA, Baxter, B. Braun Melsungen AG and Danone Nutricia are the major companies operating in the North America Clinical Nutrition Market.
What years does this North America Clinical Nutrition Market cover, and what was the market size in 2023?
In 2023, the North America Clinical Nutrition Market size was estimated at USD 28.14 billion. The report covers the North America Clinical Nutrition Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Clinical Nutrition Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
North America Medical Clinical Nutrition Industry Report
Statistics for the 2024 North America Medical Clinical Nutrition market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Medical Clinical Nutrition analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
